TRDA vs UPS · P/E 12, rev $210.8M vs P/E 15, rev $88.66B
Entrada Therapeutics Inc (TRDA) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
TRDA currently screens at market cap $274.4M and trailing P/E 12.5. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the TRDA and UPS stock pages for the full models.
Not investment advice.